Identification of an N-hydroxyguanidine reducing activity of xanthine oxidase

European Journal of Biochemistry

Volumn 257, Issue 1, 1998, Pages 178-184

  Dambrova, Maija ^a   Uhlén, Staffan ^a   Welch, Christopher J ^a   Wikberg, Jarl E S ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Guanoxabenz; N hydroxyguanidine; Reduction; Xanthine oxidase

Indexed keywords

ALLOPURINOL; ALPHA ADRENERGIC RECEPTOR; AMINO ACID; GUANABENZ; GUANIDINE DERIVATIVE; GUANOXABENZ; N HYDROXYGUANIDINE; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT;

ANIMALS; CATALYSIS; CATTLE; GUANABENZ; GUANIDINES; KINETICS; MILK; NAD; OXIDATION-REDUCTION; OXYGEN; RATS; XANTHINE OXIDASE;

ANIMALIA; BOVINAE;

EID: 0032188775     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1998.2570178.x     Document Type: Article

References (37)

1. 2-adrenoceptors in the kidney, Br. J. Pharmacol. 104, 657-664.
2. 2A- adrenoceptors in the rat, Naunyn-Schmiedebergs Arch. Pharmacol. 347, 280-288.
3. 2B-adrenoceptors in the rat, Pharmacol. Toxicol. 72, 40-49.
4. 2? in Adrenoceptors (Ruffolo, R. R., ed.) pp. 109-118, Harwood Academic Publishers, Luxembourg.
5. Kooij, A. (1994) A re-evaluation of the tissue distribution and physiology of xanthine oxidase, Histochem. J. 26, 889-915.
6. Rajagopalan, K. V. (1980) Xanthine oxidase and aldehyde oxidase, in The enzymatic basis of detoxication (Jakoby, W. B., ed.) pp. 295-309, Academic Press, New York.
7. Tatsumi, K., Kitamura S., Yoshimura H. & Kawazoe Y. (1978) Susceptibility of aromatic compounds to xanthine oxidase-catalyzed reduction, Chem. Pharm. Bull. 26, 1713-1717.
8. Tatsumi, K., Inoue A. & Yoshimura, H. (1981) Mode of reactions between xanthine oxidase and aromatic nitro componds, J. Pharm. Dyn. 4, 101-108.
9. Clement, B. & Kunze, T. (1992) The reduction of 6-N-hydroxyl-aminopurine to adenine by xanthine oxidase, Biochem. Pharmacol. 44, 1501-1509.
10. Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951) Protein measurement with the folin phenol reagent, J. Biol. Chem. 193, 265-275.
11. De Lean, A., Hancock, A. M. & Lefkowitz, R. J. (1982) Validation and statistical analysis of radioligand binding data for mixtures of pharmacological receptor subtypes, Mol. Pharm. 21, 5-16.
12. 1-adrenoceptors, Acta Pharmacol. Toxicol. 59, 270-278.
13. 2A-selective compound, Eur. J. Pharmacol. 202, 235-243.
14. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227, 680-685.
15. Nesterenko, M. V., Tilley, M. & Upton, S. J. (1994) A simple modification of Blum's silver stain method for 30 minute detection of proteins in poliacrylamide gels, J. Biochem. Biophys. Methods 28, 239-242.
16. Druper, N. R. & Smith, R. (1966) Applied regression analysis, John Willey & Sons, NY.
17. Bray, R. C. (1975) Molybdenum hydroxylases, in The enzymes, (Boyer, P. D., ed.) vol. 12B, pp. 304-326, Academic Press, NY-San Francisco-London.
18. Nagler, L. G. & Vartanyan, L. S. (1976) Subunit structure of bovine milk xanthine oxidase, effect of limited cleavage by proteolytic enzymes on activity and structure, Biochim. Biophys. Acta 427, 78-90.
19. Krenitsky, T. A., Spector, T. & Hall, W. W. (1986) Xanthine oxidase from human liver: purification and characterization, Arch. Biochem. Biophys. 247, 108-119.
20. 2-dependent type, J. Biol. Chem. 265, 14170-14175.
21. Nishino, T., Nishino, T. & Tsushima, K. (1981) Purification of highly active milk xanthine oxidase by affinity chromatography on Sepharose 4B/folate gel, FEBS Lett. 131, 369-372.
22. Nishino, T. (198694) The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury, J. Biochem. 116, 1-6.
23. Hille, R. & Massey, V. (1981) Studies on the oxidative half-reaction of xanthine oxidase, J. Biol. Chem. 256, 9090-9095.
24. Stirpe, F. & Della Corte, E. (1968) The regulation of rat liver xanthine oxidase, J. Biol. Chem. 244, 3855-3863.
25. Kutcher, W. W. & McCalla, D. R. (1984) Aerobic reduction of 5-nitro-2-furaldehyde semicarbazone by rat liver xanthine dehydrogenase, Biochem. Pharmacol. 33, 799-805.
26. Salaris, S. C., Babbs, C. F. & Voorhees, W. D. (1991) Methylene blue as an inhibitor of superoxide generation by xanthine oxidase, Biochem. Pharmacol. 42, 499-506.
27. Olson, J. S., Ballou, D. P., Palmer, G. & Massey, V. (1974) The mechanism of action of xanthine oxidase, J. Biol. Chem. 249, 4363-4382.
28. Hille, R. & Massey, V. (1981) Tight binding inhibitors of xanthine oxidase, Pharmac. Ther. 14, 249-263.
29. Massey, V. & Harris, C. M. (1997) Milk xanthine oxidoreductase: the first one hundred years, Biochem. Soc. Trans. 25, 750-755.
30. Bray, R. C. (1975) Molybdenum hydroxylases, in The enzymes (Boyer, P. D., ed.) vol. 12B, pp. 344-389. Acad Press, NY-San Francisco-London.
31. Clement, B., Demesmaeker, M. & Line, S. (1996) Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylate metabolite: Characterization of the two reactions and genotoxic potential of guanoxabenz, Chem. Res. Toxicol. 9, 682-688.
32. Clement, B. & Demesmaeker, M. (1997) Formation of guaoxnoxabenz from guanabenz in human liver. A new metabolic metabolic marker for CYP1A2, Drug Metab. Disp. 25, 1266-1271.
33. Krenitsky, T. A., Hall, W. W., De Miranda, P., Beauchamp, L. M., Schaeffer, H. J. & Whiteman, P. D. (1984) 6-Deoxyacyclovir: a xanthine oxidase-activated prodrug of acyclovir, Proc. Natl Acad. Sci. USA 81, 3209-3213.
34. White, R. C., Darley-Usmar, V., Berrington, W. R., McAdams, W. R., Gore, J. Z., Thompson, A. J., Parks, D. A., Tarpey, M. M. & Freeman, B. A. (1996) Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits, Proc. Natl Acad. Sci. USA 93, 8745-8749.
35. McCord, J. M. (1985) Oxygen-derived free radicals in postischemic tissue injury. New Engl. J. Med. 312, 159-163.
36. Saugstad, O. D. (1996) Role of xanthine oxidase and its inhibitor in hypoxia:reoxygenation injury, Pediatrics 98, 103-107.
37. Ledoux, F., Welse, M., Steimer, C. & Schwartz, J. (1981) A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action, Therapie 36, 187-191.